DAROLUTAMIDE
Manner of administration:Oral
Restriction
Indication: Castration resistant non-metastatic carcinoma of the prostate
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 112 | # of repeats: 5 | DPMQ: $3,538.57 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Nubeqa | |||||
Manner of administration:Oral
Restriction
Indication: Metastatic castration sensitive carcinoma of the prostate
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 112 | # of repeats: 5 | DPMQ: $3,538.57 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Nubeqa | |||||